Armata Pharmaceuticals, Inc. (ARMP)
5.84
+0.32
(+5.80%)
USD |
NYAM |
Sep 04, 16:00
5.83
-0.01
(-0.17%)
After-Hours: 20:00
Armata Pharmaceuticals Total Liabilities (Quarterly) : 321.12M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 321.12M |
| March 31, 2026 | 381.39M |
| December 31, 2025 | 304.78M |
| September 30, 2025 | 185.10M |
| June 30, 2025 | 150.29M |
| March 31, 2025 | 141.03M |
| December 31, 2024 | 147.35M |
| September 30, 2024 | 149.21M |
| June 30, 2024 | 154.41M |
| March 31, 2024 | 176.87M |
| December 31, 2023 | 142.03M |
| September 30, 2023 | 125.15M |
| June 30, 2023 | 82.07M |
| March 31, 2023 | 86.33M |
| December 31, 2022 | 71.80M |
| September 30, 2022 | 47.30M |
| June 30, 2022 | 47.69M |
| March 31, 2022 | 46.23M |
| December 31, 2021 | 54.40M |
| September 30, 2021 | 18.92M |
| June 30, 2021 | 19.66M |
| March 31, 2021 | 18.83M |
| December 31, 2020 | 23.68M |
| September 30, 2020 | 21.06M |
| June 30, 2020 | 19.82M |
| Date | Value |
|---|---|
| March 31, 2020 | 10.62M |
| December 31, 2019 | 10.86M |
| September 30, 2019 | 11.17M |
| June 30, 2019 | 12.29M |
| March 31, 2019 | 4.656M |
| December 31, 2018 | 6.851M |
| September 30, 2018 | 3.766M |
| June 30, 2018 | 3.381M |
| March 31, 2018 | 3.109M |
| December 31, 2017 | 3.407M |
| September 30, 2017 | 4.024M |
| June 30, 2017 | 5.245M |
| March 31, 2017 | 7.654M |
| December 31, 2016 | 8.472M |
| September 30, 2016 | 7.808M |
| June 30, 2016 | 7.795M |
| March 31, 2016 | 5.749M |
| December 31, 2015 | 6.889M |
| September 30, 2015 | 7.474M |
| June 30, 2015 | 19.26M |
| March 31, 2015 | 39.35M |
| December 31, 2014 | 23.19M |
| September 30, 2014 | 25.90M |
| June 30, 2014 | 51.31M |
| March 31, 2014 | 61.42M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Agenus, Inc. | 378.54M |
| Amgen, Inc. | 83.95B |
| Anika Therapeutics, Inc. | 46.19M |
| BioCryst Pharmaceuticals, Inc. | 1.012B |
| Imunon, Inc. | 10.80M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 89.95M |
| Shareholders Equity (Quarterly) | -231.17M |
| Debt to Equity Ratio | -1.358 |
| Current Ratio | 0.1085 |
| Net Debt Paydown Yield | -14.90% |